Other
A Two Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of Pramipexole IR versus Ropinirole in Early Parkinson's Disease Patients
(2007)
Disciplines
Publication Date
2007
Citation Information
Kelly L. Sullivan (Coordinator), "A Two Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of Pramipexole IR versus Ropinirole in Early Parkinson's Disease Patients," Boehringer Ingelheim, Protocol # 248.538. (2007-2011).